Across Europe , discussion surrounding copyright as a option for psychiatric conditions is increasing . While previously viewed primarily as an anesthetic agent, its efficacy in treating depression , particularly treatment-resistant cases, is fueling a considerable alteration in medical approaches . However , access remains complex and varies widel